Chronically culturing HIT-T15 cells in media containing high glucose concentrations leads to decreased insulin mRNA levels, insulin content, and insulin secretion. These changes can be prevented by culturing the cells in media containing lower glucose levels
March 1993. insulin secretion, the so-called glucose toxicity theory (reviewed in references 1 and 2). Normalization ofblood glucose levels of type II diabetic patients partially restores defective insulin release (3) (4) (5) (6) (7) , and normalization of glucose levels in several hyperglycemic animal models leads to full restoration of normal insulin secretion (8) (9) (10) . However, no biochemical mechanism has been identified for glucotoxic effects on the pancreatic ,3 cell (2). Our previous observations ( 11 ) suggested that one potential explanation could involve an alteration in insulin gene expression.
The HIT-T 15 cell is a clonal pancreatic ,3 cell line derived from SV-40 transfected Syrian hamster pancreatic islets ( 12) . This cell line synthesizes and releases insulin in response to physiological secretagogues including glucose (13) (14) (15) (16) (17) (18) . However, the HIT cell loses its ability to secrete insulin with increasing passage ( 12, 14, 18) . Recently, Robertson et al. have shown that the loss of insulin secretion is associated with decreased insulin content and insulin mRNA, and that this loss can be prevented by passaging HIT cells in low glucose (0.8 mM) rather than the high glucose ( 1 1.1 mM) concentrations usually used when culturing these cells ( 11) . The studies reported here were designed to determine whether a seemingly paradoxical decrease in insulin gene transcription might be a mechanism through which chronically culturing HIT cells in high glucose concentrations decreases insulin content and insulin mRNA.
We sought to answer three questions: (a) Does 37 'C in RPMI-1640 media containing 10% FBS and 11.1 mM glucose, and passaged weekly after trypsin-EDTA detachment ( 18) . Beginning at passage 70, HIT cells were split weekly and continuously cultured in RPMI-1640 containing either 1 1.1 or0.8 mM glucose through passage 140 ( 11). These concentrations were chosen because they stimulate insulin release at either extreme of the HIT cell insulin response curve ( 18 ) . 
The plasmid INSCAT, containing the human insulin gene sequences -326 to +30, was constructed as follows. The sequences from -326 to +30 were amplified by PCR using oligodeoxynucleotides Ins(-326/-307) and Ins(+l l/+30) as primers and phins 300 plasmid containing the human insulin gene (a gift from Dr. Graeme I. Bell, Howard Hughes Medical Institute and the University of Chicago) as a template. XbaI and XhoI sites were present on the 5'-and 3'-ends ofthe primers used for PCR, respectively. This DNA fragment was cleaved with XbaI and XhoI and then subcloned into the XbaI and XhoI sites of pCAT(An), a promoterless plasmid containing the bacterial chloramphenicol acetyl transferase (CAT)' gene (19) .
Plasmids containing mutations in the CT motifs of the insulin promoter region were constructed by a PCR-based mutagenesis technique. The mCT2CAT plasmid was constructed by PCR amplification of se- has a BssHII site replacing the native insulin gene sequences at -82/ -77. The -326 to -65 PCR product was then cleaved with XbaI and BssHII, while the -94 to +30 PCR product was cleaved with XhoI and BssHII. These PCR products were then subcloned into the XbaI and XhoI sites of pCAT(An). The mCTlCT2CAT plasmid was constructed by the same method as for the mCT 1CAT plasmid except that the mCT2CAT plasmid was used as the DNA template during PCR. Proper insertion and confirmation of sequence for all vectors were determined by dideoxy sequencing.
Cell transfections and CAT assay. HIT cells were subcultured in RPMI-1640 containing 11.1 mM glucose at a density of 1.2 x 106 cells per well in 6-well plates (diameter 3.5 cm) 2 d before each study. Duplicate wells of cells were then transfected with 0.5 to 1.0 ug of INSCAT DNA or 0.1 to 0.5 ug of RSVCAT DNA by a liposome-mediated method (Lipofectin; BRL, Gaithersburg, MD). All transfections and subsequent incubations were done in 11.1 mM glucose. Cells were rinsed with FBS-free RPMI-1640, then 1 ml of FBS-free RPMI-1640 containing 1:4 (wt:wt) plasmid DNA to lipofectin was added and cells were incubated for 5 h at 37°C, after which 2 ml RPMI-1640 containing 15% FBS was added. 30 h after transfection, cells were harvested and CAT activity was assayed (20) . Data are expressed as relative INS-1. Abbreviations used in this paper: CAT, chloramphenicol acetyl transferase; EMSA, electrophoretic shift assay; GSTF, glucose-sensitive transcription factor.
CAT to RSVCAT expression to control for variability in transfection efficiency observed between cells cultured in low and high glucose concentrations.
Nuclear extracts and electrophoretic mobility shift assay (EMSA). 1 mM glucose appears to be specific for INSCAT expression, since RSVCAT expression was the same for both early and late passages of HIT cells (Table I) .
Compared with late passages of HIT cells chronically cultured in 1 1.1 mM glucose, cells chronically cultured in 0.8 mM glucose expressed 2.4-fold (P < 0.005, n = 5) more relative CAT activity when transfected with INSCAT (Table I ). In late passages of HIT cells serially passaged in 0.8 mM glucose, insulin promoter activity was shown to be 69.6±10.0% compared with early passages of cells (Table I) . When early and late passages ofHIT cells chronically cultured in either I 1.1 mM or 0.8 mM glucose were cotransfected with both INSCAT and a RSVdriven luciferase reporter construct, to control for transfection efficiency, qualitatively similar results to those described in Table I were observed (data not shown). These data suggest that late passages of HIT cells chronically cultured in 0.8 mM glucose have preserved insulin promoter activity, which may explain the preservation of both insulin mRNA and insulin content (11). With an oligodeoxynucleotide probe containing sequences -230/-201 ofthe human insulin gene, at least 5 DNA-protein complexes were detected when using nuclear extracts from early passages of cells (Fig. 1 A, lane 2) . Of these, one prominent DNA-protein complex was absent in nuclear extracts from late passages of HIT cells cultured in 11.1 mM glucose (Fig. 1 A, lane 3) . In contrast, nuclear extracts made from later passages of cells serially passaged in 0.8 mM glucose retained the ability to form this DNA-protein complex (Fig. 1 A, lane  4) . The specificity ofthe DNA-protein complexes formed with the different extracts was determined by use of an excess of unlabeled DNA from -230/-201 to compete for binding( Fig.  1 A, lanes 5-7) . This slow mobility complex, present in early passages and late passages of cells cultured in 0.8 mM glucose and absent in late passages of cells cultured in 11.1 mM glucose, is designated as the glucose-sensitive transcription factor (GSTF). To validate that the loss of a specific DNA binding protein in nuclear extracts from HIT cells serially passaged in 0.8 mM glucose was not due to an aberration of the nuclear extraction, we tested the various preparations for activity ofthe ubiquitous MLTF nuclear factor. All the HIT cell nuclear extractions shifted an MLTF DNA probe to the same extent (data not shown), suggesting that all the nuclear preparations were active. Furthermore, several other nuclear factors binding to the -230/-201 fragment were also unchanged in the different preparations (Fig. 1 A) .
The oligodeoxynucleotide probe containing the sequences -249/ -220 of the human insulin gene was used to search for changes in other DNA binding proteins from HIT cells passaged either in 11.1 mM or 0.8 mM glucose. Nuclear extracts from early and late passages of HIT cells serially passaged in 11.1 or 0.8 mM glucose shifted this oligodeoxynucleotide to the same extent ( Fig. 1 B) . These data demonstrate that the differences in INSCAT expression in the early and late passages of HIT cells serially passaged in either 11.1 mM or 0.8 mM (B) EMSA using 32P-labeled insulin promoter sequence -249 to -220. Lane 1, free probe; lanes 2-4, nuclear extracts from HIT cell passage 74 and passage 133 serially passaged in 11.1 mM glucose and 0.8 mM glucose, respectively. This figure represents results observed for two independent nuclear extractions from each HIT cell passage described. These data also represent a minimum of three independent experiments per condition (n = 3). glucose are not due to changes in the binding of nuclear factors to this strong enhancer element.
The CT2 motif (CTAATG) located at -215 / -210 of the human insulin promoter has previously been shown to be the binding site for a transcription factor, IUF-1 (25) . To test whether this sequence might be a site for binding ofGSTF, the sequence CTAATG was mutated to ACGCGT in the -230/ -201 oligodeoxynucleotide. This mutated oligodeoxynucleotide no longer competed for the specific DNA-protein complex that was only present in the early passages cells and late passages ofHIT cells serially passaged in 0.8 mM glucose (Fig. 1 A,  lanes 8-J10) . These data suggest that GSTF binds to the IUF-1 binding site.
Since GSTF appeared to bind the CT2 motif, the nuclear extracts from the various HIT cell passages were tested for binding to an oligodeoxynucleotide containing the sequences -94/ -65 of the human insulin gene. This oligodeoxynucleotide probe contains the CTl motif (CTAATG), located at -82/ -77 of the human insulin promoter, which has been shown to be an additional binding site for IUF-1 (25) . With the -94/ -65 oligodeoxynucleotide probe, one prominent DNA-protein complex was observed with nuclear extracts from passage 74 cells (Fig. 2, lane 2) . Nuclear extracts from passage 133 HIT cells chronically cultured in 1 1.1 mM glucose were unable to form this DNA-protein complex (Fig. 2, lane 3) . In contrast, nuclear extracts from passage 133 HIT cells chronically cultured in 0.8 mM glucose retained the ability to form this DNAprotein complex (Fig. 2, lane 4) passage 74 was determined by using an excess of unlabeled -94/-65 deoxynucleotide probe to compete for binding (Fig.   2, lanes 5, 6) .
The protein-DNA complex formed with the HIT cell passage 74 nuclear extract and the -94/ -65 oligodeoxynucleotide was directly competed by the addition of excess unlabeled -230/-201 DNA (Fig. 2, lanes 9, 10) . These data suggest that the transcription factor present in nuclear extracts from passage 74 (Fig. 2, lanes  7, 8) . Overall these data suggest that GSTF binds to the CT motifs, which have been previously shown to bind IUF-1.
Mutations of GSTF binding sites within S'-regulatory domain ofthe human insulin gene lead to decreased expression of INSCA T reporter gene. To test whether the loss ofGSTF correlates to the decreased expression of INSCAT in late passages of HIT cells serially passaged in 1 1.1 mM glucose, site-directed mutations of the GSTF binding sites within the INSCAT vector were constructed and tested in the various HIT cell passages. Three mutant INSCAT vectors were constructed; mCT2CAT in which the CT2 motif was mutated to ACGCGT, mCT 1CAT in which the CT I motifwas mutated to GCGCGC, and mCTlCT2CAT in which the CTl and CT2 motifs were mutated to GCGCGC and ACGCGT, respectively. The expression of the mCTlCT2CAT vector, in which both GSTF binding sites were mutated, is markedly decreased in early passages of HIT cells and in late passages of HIT cells cultured in either 1 1.1 mM or 0.8 mM glucose (Fig. 3) . Mutation of the individual GSTF binding sites (mCTlCAT or mCT2CAT) also tended to decrease CAT expression in all HIT cell passages, but these effects were not always statistically significant. These data indicate that the GSTF binding sites present within the 5'-regulatory domain of the human insulin gene play a functional role in the regulation of insulin gene transcription and that the loss of GSTF binding leads to decreased insulin gene transcription. 
Discussion
In experiments designed to examine potentially adverse effects of high glucose concentrations on insulin gene transcription, we found that the activity of the insulin gene promoter is decreased in HIT cells serially passaged in maximally stimulatory concentrations of glucose. This can be partially prevented by culturing HIT cells in a lower glucose concentration. The changes in the activity of the insulin promoter correlate with changes in insulin mRNA levels for the different HIT cell passages ( 11 ) . The observation that chronic exposure of HIT cells to high glucose concentration leads to decreased insulin gene expression represents an apparent time-related paradox. Acute increases in glucose concentrations have been shown to increase insulin mRNA levels (26) (27) (28) (29) (30) is transcribed (26, 31, 32) . The chronic effect of glucose on insulin gene transcription that we describe and which can be partially prevented by chronically culturing HIT cells in lower glucose concentrations, may represent a direct glucose toxic effect on a insulin-gene specific transcription factor(s). A glucose-responsive DNA element has been mapped to -247/-196 ofthe rat 1 insulin gene enhancer (31) . Both ubiquitous transcription factors, Pan-l and Pan-2 (33) (34) (35) (36) , and ( cell specific factors (37) (38) (39) have been shown to bind to DNA sequences contained in this glucose-responsive region. A , cell specific factor (IUF-1) binds to the CT motifs (CTAATG) located at -215 /-2 10 (CT2 motif) and -82/-77 (CTl motif) in the human insulin gene enhancer (25) . The CT motifs are highly conserved across all mammalian species, suggesting that these motifs may participate in the transcriptional regulation of the insulin gene. The CT2 motif of the human insulin gene is similar to sequences located in the FLAT element (-222/ -208) of rat 1 insulin gene (40) . Mutations of the FLAT element have been shown to decrease the rat 1 insulin gene promoter activity (41) and to alter the activity of a rat 1 insulin gene mini-enhancer linked to a heterologous promoter (40) . Recently, German et al. has cloned two protein factors, lmx-1 and cdx-3, which bind to the FLAT element (42) . Lmx-1, a (3 cell specific LIM-homeo domain protein, synergistically interacts with Pan-1 and increases the expression ofthe rat 1 insulin gene mini-enhancer in nonpancreatic beta cells (42) . However, the relationship between IUF-1 and FLAT element binding proteins, lmx-1 and cdx-3, has yet to be determined.
Our data show that nuclear extracts made from late passages of HIT cells chronically cultured in a high glucose concentration fail to form a specific DNA-protein complex (GSTF) to sequences -230/-201 and -94/-65 ofthe human insulin gene and that GSTF requires the CT motifs contained within these sequences for binding. Our studies also demonstrate that mutations of the CT motifs decrease insulin promoter activity in all passages of HIT cells. These data suggest that the CT motifs play a functional role in the regulation ofthe human insulin gene promoter activity. Our findings strongly suggest that the mechanism ofaction for the decrease in insulin gene transcription in cells cultured chronically in high glucose concentrations is the loss of GSTF binding to the CT motifs either because GSTF has been altered or is no longer present. The exact relationship between IUF-1 and GSTF has not been resolved, but they may be closely related to the FLAT binding proteins, lmx-1 or cdx-3. The decrease in insulin gene transcription is not due to the loss of a transcription factor that binds to the strong enhancer element located between -249 and -220 of the human insulin gene because similar levels of DNA-protein complexes, assessed by EMSA, were formed when using nuclear extracts from HIT cells chronically cultured in high or low glucose concentrations.
The loss of insulin response to glucose in HIT cells serially passaged in high glucose concentrations and the ability to prevent this by passaging cells in a more physiological glucose concentration is reminiscent of the adverse effects of chronic hyperglycemia which occur in patients with type II diabetes mellitus and animal models fed excess glucose. Although it is generally thought that such glucose toxic effects occur at sites within the exocytotic pathway, our results suggest that these adverse effects occur at the level ofthe insulin gene and lead to a paradoxical decrease in the rate of transcription. Recently published data demonstrated that prolonged exposure of the human pancreatic islet to high glucose concentrations leads to impaired insulin secretion (43) . This was attributed mainly to a decline in insulin content that was preventable by culturing the islets in low glucose concentrations (43) . This conclusion is consistent with our suggestion that d cells are sensitive to direct glucose toxic effects on insulin gene transcription. We therefore propose a time-related distinction between the terms glucose desensitization and glucose toxicity. The former may be a more acute, reversible phenomenon at the level of insulin exocytosis, whereas the latter may be a more chronic, less reversible phenomenon at the level of insulin gene transcription.
To the extent that one can generalize from observations in HIT cells to the pathophysiology in type II diabetic patients, our data suggest that close regulation ofglucose concentrations in type II diabetic patients might provide the previously unanticipated benefit of helping preserve insulin gene expression. A corollary of this logic is that prolonged hyperglycemia, despite treatment with oral hypoglycemic agents, may contribute to deterioration of insulin production and secretion and, thus, lead to so-called "secondary failure" of these drugs.
